Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epigenetic regulation refers to the control of gene expression that occurs without altering the underlying DNA sequence. It involves chemical modifications to DNA, histone proteins, chromatin structure, and non-coding RNAs that collectively determine whether genes are turned on or off. Key mechanisms include DNA methylation, histone modifications, chromatin remodeling, and non-coding RNA-mediated regulation. Epigenetic regulation is essential for cell differentiation, maintenance of cellular identity, developmental programming, and response to environmental stimuli. It plays a role in disease states such as cancer, cardiovascular diseases, neurological disorders, and metabolic syndromes. Targeting epigenetic regulators has become a promising strategy in treating cancers and other diseases where abnormal epigenetics drive pathology.
Drugs targeting epigenetic regulators aim to reverse aberrant epigenetic modifications, restoring normal gene expression patterns. DNMT inhibitors reduce DNA methylation, while HDAC inhibitors increase histone acetylation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epigenetic Regulation.